| Biomarker ID | 1369 |
| PMID | 24668563 |
| Year | 2014 |
| Biomarker | Hyaluronan-Mediated Motility Receptor (HMMR) |
| Biomarker Basis | Expression Based |
| Biomolecule | Metabolites |
| Source | Tissue |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: Univariate: 2.00 (95% CI: 1.08-3.71); Multivariate: 2.03 (95% CI: 1.04-3.99) |
| Effect on Pathways | Pathways include: Hyaluronan metabolism, ECM-receptor interaction, Glycosaminoglycan metabolism, Carbohydrate metabolism, Metabolism |
| Experiment | Biochemical Failure Vs No Biochemical Faliure |
| Type of Biomarker | Prognostic |
| Cohort | 96 patients with Prostate Cancer were chosen for the analysis. For HMMR results: 89 patients were avaliable out of which 13 experienced Biochemical Failure |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | Univariate: p=0.028; Multivariate: p=0.04 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |